Tokyo Tape
Sign in
← Ono Pharmaceutical

Quarterly report · Q3

4528.TEDINET S100Q0U7
Period2022-04-01 → 2022-12-31
Filed2023-02-03
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥339.0bn2022-04-01 → 2022-12-31Cons.Revenue IFRS
Revenue¥122.3bn2022-10-01 → 2022-12-31dCons.Revenue IFRS
Revenue¥361.4bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥271.4bn2021-04-01 → 2021-12-31Cons.Revenue IFRS
Revenue¥97.4bn2021-10-01 → 2021-12-31dCons.Revenue IFRS
Operating income¥122.6bn2022-04-01 → 2022-12-31Cons.Operating profit loss IFRS
Operating income¥42.3bn2022-10-01 → 2022-12-31dCons.Operating profit loss IFRS
Operating income¥82.2bn2021-04-01 → 2021-12-31Cons.Operating profit loss IFRS
Operating income¥24.0bn2021-10-01 → 2021-12-31dCons.Operating profit loss IFRS
Profit before tax¥124.4bn2022-04-01 → 2022-12-31Cons.Profit loss before tax IFRS
Profit before tax¥43.4bn2022-10-01 → 2022-12-31dCons.Profit loss before tax IFRS
Profit before tax¥105.0bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥84.3bn2021-04-01 → 2021-12-31Cons.Profit loss before tax IFRS
Profit before tax¥25.1bn2021-10-01 → 2021-12-31dCons.Profit loss before tax IFRS
Net income (owners)¥95.7bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥33.3bn2022-10-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥80.5bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥64.6bn2021-04-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥18.3bn2021-10-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS
Net income¥95.8bn2022-04-01 → 2022-12-31Cons.Profit loss IFRS
Net income¥33.4bn2022-10-01 → 2022-12-31dCons.Profit loss IFRS
Net income¥64.7bn2021-04-01 → 2021-12-31Cons.Profit loss IFRS
Net income¥18.3bn2021-10-01 → 2021-12-31dCons.Profit loss IFRS
Total assets¥830.5bnat 2022-12-31Cons.Assets IFRS
Total assets¥739.2bnat 2022-03-31Cons.Assets IFRS
Total assets¥738.6bnat 2021-12-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥103.2bnat 2022-12-31Cons.Liabilities IFRS
Total liabilities¥77.5bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥727.3bnat 2022-12-31Cons.Equity IFRS
Net assets / equity¥661.7bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥664.9bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥639.7bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥721.4bnat 2022-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥655.9bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥659.3bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥108.6bnat 2022-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥69.1bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥62.5bnat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥61.0bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥115.1bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥61.8bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥27.4bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥44.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥6.0bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow¥18.1bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥30.9bn2022-04-01 → 2022-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥60.2bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥44.2bn2021-04-01 → 2021-12-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥195.92022-04-01 → 2022-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥68.232022-10-01 → 2022-12-31dCons.Basic earnings loss per share IFRS
EPS (basic)¥162.192021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥129.612021-04-01 → 2021-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥36.832021-10-01 → 2021-12-31dCons.Basic earnings loss per share IFRS
EPS (diluted)¥195.882022-04-01 → 2022-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥68.222022-10-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥162.162021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥129.592021-04-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥36.822021-10-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS
Equity ratio86.9%at 2022-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio88.7%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio89.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 575
ItemContextValueUnit
Non controlling interests IFRSPrior1YearInstant5768000000JPY
Non controlling interests IFRSCurrentQuarterInstant5921000000JPY
Equity IFRSPrior1YearInstant661674000000JPY
Equity IFRSCurrentQuarterInstant727307000000JPY
Liabilities and equity IFRSPrior1YearInstant739203000000JPY
Liabilities and equity IFRSCurrentQuarterInstant830539000000JPY
Revenue IFRSPrior1YTDDuration271430000000JPY
Revenue IFRSCurrentYTDDuration339020000000JPY
Cost of sales IFRSPrior1YTDDuration70634000000JPY
Cost of sales IFRSCurrentYTDDuration83787000000JPY
Gross profit IFRSPrior1YTDDuration200796000000JPY
Gross profit IFRSCurrentYTDDuration255233000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration57488000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration66147000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration49464000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration65974000000JPY
Other income IFRSPrior1YTDDuration745000000JPY
Other income IFRSCurrentYTDDuration518000000JPY
Other expenses IFRSPrior1YTDDuration12422000000JPY
Other expenses IFRSCurrentYTDDuration1041000000JPY
Operating profit loss IFRSPrior1YTDDuration82167000000JPY
Operating profit loss IFRSCurrentYTDDuration122590000000JPY
Finance income IFRSPrior1YTDDuration2537000000JPY
Finance income IFRSCurrentYTDDuration2409000000JPY
Finance costs IFRSPrior1YTDDuration353000000JPY
Finance costs IFRSCurrentYTDDuration624000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-2000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration4000000JPY
Profit loss before tax IFRSPrior1YTDDuration84349000000JPY
Profit loss before tax IFRSCurrentYTDDuration124379000000JPY
Income tax expense IFRSPrior1YTDDuration19680000000JPY
Income tax expense IFRSCurrentYTDDuration28551000000JPY
Profit loss IFRSPrior1YTDDuration64669000000JPY
Profit loss IFRSCurrentYTDDuration95827000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration64620000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration95656000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration48000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration172000000JPY
Profit loss IFRSPrior1YTDDuration64669000000JPY
Profit loss IFRSCurrentYTDDuration95827000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration129.61
Basic earnings loss per share IFRSCurrentYTDDuration195.90
Diluted earnings loss per share IFRSPrior1YTDDuration129.59
Diluted earnings loss per share IFRSCurrentYTDDuration195.88
Revenue IFRSPrior1QuarterDuration97353000000JPY
Revenue IFRSCurrentQuarterDuration122319000000JPY
Cost of sales IFRSPrior1QuarterDuration25067000000JPY
Cost of sales IFRSCurrentQuarterDuration30075000000JPY
Gross profit IFRSPrior1QuarterDuration72285000000JPY
Gross profit IFRSCurrentQuarterDuration92244000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2021-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-12-31pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2021-04-01/2021-12-31pass
statement vs summary · revenueconsolidated 2021-10-01/2021-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2022-10-01/2022-12-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-12-31pass